miR-155 Predicts Long-Term Mortality in Critically Ill Patients Younger than 65 Years.

Frank TackeMartina E SpehlmannMihael VucurFabian BenzMark LueddeDavid Vargas CardenasSanchari RoySven LoosenHans-Joerg HippeNorbert FreyChristian TrautweinAlexander KochChristoph Roderburg Tom Luedde

Published in: Mediators of inflammation (2019)

In summary, the data provided within this study suggest an age-specific role of miR-155 as a prognostic biomarker in patients younger than 65 years. Our study is the first to describe an age-dependent miRNA-based prognostic biomarker in human diseases.

Keyphrases

cell proliferation
long non coding rna
end stage renal disease
endothelial cells
newly diagnosed
long noncoding rna
ejection fraction
type diabetes
cardiovascular disease
peritoneal dialysis
prognostic factors
machine learning
induced pluripotent stem cells